Skip to main content

Table 2 Baseline Acute Headache Medication Use in Patients With CMa

From: Long-term study of the efficacy and safety of OnabotulinumtoxinA for the prevention of chronic migraine: COMPEL study

Medication Use, n (%)

Enrolled Population N = 716

Acute headache medication use

639 (89.2)

 Triptans

383 (53.5)

 Simple analgesics

327 (45.7)

 Combination analgesics

225 (31.4)

 Opioids

117 (16.3)

 Ergotamines

53 (7.4)

Acute headache medication overuseb

456 (63.7)

 Triptans (≥10 d)

194 (27.1)

 Combination analgesics (≥10 d)

88 (12.3)

 Simple analgesics (≥15 d)

79 (11.0)

 Opioids (≥10 d)

38 (5.3)

 Ergotamines (≥10 d)

18 (2.5)

  1. CM chronic migraine
  2. aData from patients with ≥20 d of data in their patient diary
  3. bDefinition of medication overuse is based on 4 wk. diary data